US 11,878,968 B2
Aryl compounds and pharmaceutical compositions that modulate IKZF2
Pengyu Yang, San Diego, CA (US); and Simon Bailey, San Diego, CA (US)
Assigned to Plexium, Inc., San Diego, CA (US)
Filed by Plexium, Inc., San Diego, CA (US)
Filed on Nov. 3, 2022, as Appl. No. 18/052,462.
Application 18/052,462 is a continuation of application No. 17/860,922, filed on Jul. 8, 2022, abandoned.
Claims priority of provisional application 63/314,992, filed on Feb. 28, 2022.
Claims priority of provisional application 63/220,323, filed on Jul. 9, 2021.
Prior Publication US 2023/0265071 A1, Aug. 24, 2023
Int. Cl. C07D 401/14 (2006.01); A61P 35/00 (2006.01)
CPC C07D 401/14 (2013.01) 40 Claims
 
1. A compound selected from:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt, solvate, stereoisomer, or tautomer thereof.